Therapeutics

Tools

Back to the Top
Search By Attributes

Search Results

Name Synonyms FDA Status Company Target Type Therapy Type Approved
For
E2814 Alzheimer's Disease (Phase 1/2) Eisai Co., Ltd. Tau Immunotherapy (passive)
Pepinemab VX15,
VX15/2503
Alzheimer's Disease (Phase 1/2), Huntington's Disease (Phase 2) Vaccinex, Inc. Inflammation Immunotherapy (passive)